25682-022-01 |
25682-022 |
HUMAN PRESCRIPTION DRUG |
Ultomiris |
ravulizumab |
SOLUTION, CONCENTRATE |
INTRAVENOUS |
20181221 |
N/A |
BLA |
BLA761108 |
Alexion Pharmaceuticals Inc. |
RAVULIZUMAB |
300 mg/30mL |
1 VIAL, GLASS in 1 CARTON (25682-022-01) / 30 mL in 1 VIAL, GLASS |
25682-025-01 |
25682-025 |
HUMAN PRESCRIPTION DRUG |
Ultomiris |
ravulizumab |
SOLUTION, CONCENTRATE |
INTRAVENOUS |
20201009 |
N/A |
BLA |
BLA761108 |
Alexion Pharmaceuticals Inc. |
RAVULIZUMAB |
300 mg/3mL |
1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS |
25682-028-01 |
25682-028 |
HUMAN PRESCRIPTION DRUG |
Ultomiris |
ravulizumab |
SOLUTION, CONCENTRATE |
INTRAVENOUS |
20201009 |
N/A |
BLA |
BLA761108 |
Alexion Pharmaceuticals Inc. |
RAVULIZUMAB |
1100 mg/11mL |
1 VIAL, GLASS in 1 CARTON (25682-028-01) / 11 mL in 1 VIAL, GLASS |
25682-031-01 |
25682-031 |
HUMAN PRESCRIPTION DRUG |
ULTOMIRIS |
RAVULIZUMAB |
KIT |
|
20230401 |
N/A |
BLA |
BLA761108 |
Alexion Pharmaceuticals Inc. |
|
|
1 KIT in 1 CARTON (25682-031-01) * 1 CARTRIDGE in 1 TRAY / 3.5 mL in 1 CARTRIDGE |